Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
The main treatment for pemphigus vulgaris are systemic corticosteroids and immunosuppressive agents, but due to adverse reactions and therapeutic failure, new drugs such as rituximab and mycophenolate mofetil have been used. In this case report are described two cases of severe pemphigus vulgaris re...
Saved in:
Main Authors: | Stephanie Del Rio Navarrete Biot (Author), Joanna Pimenta de Araujo Franco (Author), Ricardo Barbosa Lima (Author), Henrique Novo Costa Pereira (Author), Luiz Paulo José Marques (Author), Carlos José Martins (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Dermatologia,
2014-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastrointestinal cytomegalovirus disease in a patient with pemphigus vulgaris treated with corticosteroid and mycophenolate mofetil
by: Luiza Barbosa Oliveira, et al.
Published: (2017) -
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
by: Martini G, et al.
Published: (2008) -
A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus
by: Ishikawa Y, et al.
Published: (2018) -
Effectiveness of cyclosporine and mycophenolate mofetil in a child with refractory evans syndrome
by: Piero Farruggia, et al.
Published: (2011) -
Severe recalcitrant otic lichen planus treated with mycophenolate mofetil
by: Lisa N. Guo, BS, et al.
Published: (2021)